All posts by: Michael Zand

About Michael Zand

Osiris Therapeutics (OSIR) to Sell Mesenchymal Stem Cell Unit – StreetInsider.com (subscription)

Osiris Therapeutics (OSIR) to Sell Mesenchymal Stem Cell UnitStreetInsider.com (subscription)Osiris Therapeutics, Inc. (Nasdaq: OSIR) and Mesoblast Limited, through its wholly owned subsidiary, Mesoblast International Sárl (“Mesoblast”), entered into a Purchase Agreement, dated October 10, 2013, pursuant to the terms of which the Company sold … …read more   &nbs… Continue reading

2013-10-11 NEWS